Bioelectronics Corp (BIEL)

[av8tor65]

PharmoEvo response to me concerning ActiPatch:

Hello.

"The response is majorly positive so far. We're promoting it via detailing to HCP's segment of Orthopedic, Neurophysicians, Physicians and Rheumatologists etc. 80-85% patients have received pain relief from the device but there is some 10-15% population that has not got desired results.

We're up for it to making a trend setter in chronic pain management".